|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||
|
||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sBC7A4426-5BC6-11EF-8BEB-FC4185CE164B&I=39IZM&T=&OP=Display&O=html&O1=15318206&O2=954925508356&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DCarboplatin%252C%2520continuous%2520infusion%2520fluorouracil%2520and%2520mid-cycle%2520high-dose%2520methotrexate%2520as%2520initial%2520treatment%2520in%2520patients%2520with%2520locally%2520advanced%2520head%2520and%2520neck%2520cancer.%2520Hellenic%2520Co-operative%2520Oncology%2520Group%2520Study%26rft.au%3DFountzilas%252C%2520G%26rft.au%3DKosmidis%252C%2520P%26rft.au%3DMakrantonakis%252C%2520P%26rft.au%3DSridhar%252C%2520K%2520S%26rft.date%3D1991-10-31%26rft.eissn%3D2038-2529%26rft.externalDocID%3D1781038%26rft.genre%3Darticle%26rft.issn%3D0300-8916%26rft.issue%3D5%26rft.jtitle%3DTumori%26rft.spage%3D426%26rft.volume%3D77%26rft_id%3Dinfo%253Apmid%252F1781038%26rft_id%3Dinfo%253Apmid%252F1781038%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-MESSAGE_NO_FULLTXT_LCL-getMessageNoFullTxt-object,2-COBIB_SI_LCL-getHolding-object,3-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,4-ISI_WEB_OF_SCIENCE-getAuthor-object,5-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,6-REFWORKS_EXPORT_TOOL-getReference-object,7-NCBI_PUBMED_FREE-getCitedRecord-object,8-GOOGLE_SCHOLAR_FREE-getWebSearch-object,9-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.983588&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15318206-sBC7A4426-5BC6-11EF-8BEB-FC4185CE164B" timestamp="2024-08-16T13:57:42Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:954925508356</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Carboplatin, continuous infusion fluorouracil and mid-cycle high-dose methotrexate as initial treatment in patients with locally advanced head and neck cancer. Hellenic Co-operative Oncology Group Study</jnl:atitle>
<jnl:jtitle>Tumori Journal</jnl:jtitle>
<jnl:date>1991-10-31</jnl:date>
<jnl:spage>426</jnl:spage>
<jnl:coden>TUMOAB</jnl:coden>
<jnl:issn>0300-8916</jnl:issn>
<jnl:volume>77</jnl:volume>
<jnl:issue>5</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2038-2529</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:coden>TUMOAB</jnl:coden>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:2fdf4d8f764be8d0135cf65facac6a625ac4bc14</ctx:identifier>
<ctx:identifier>urn:UUID:sBC7A4426-5BC6-11EF-8BEB-FC4185CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)